Repligen

Repligen RGEN Stock

$162.78   -2.985870%
Add to favorites
Market Cap
$10.41B
LOW - HIGH [24H]
$162.48 - $166.79
VOLUME [24H]
$575.42K
P/E Ratio
0
Earnings per share
-$0.21
ISIN
US7599161095
Price   Prediction

Repligen Price Chart

Sorry, that's all we've gotfor now...

Repligen (RGEN) stock price today is 162.78 USD on Tech Market Large (-2.99% on the day). Updated .

Repligen RGEN Financial and Trading Overview

Repligen stock price 162.78 USD
Previous Close 167.79 USD
Open 166.14 USD
Bid 151.96 USD x 200
Ask 178.79 USD x 200
Day's Range 162.48 - 166.79 USD
52 Week Range 100.99 - 198.87 USD
Volume 575.42K USD
Avg. Volume 1.19M USD
Market Cap 10.41B USD
Beta (5Y Monthly) 1.117
PE Ratio (TTM) N/A
EPS (TTM) -0.21 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 203.21 USD

RGEN Valuation Measures

Enterprise Value 10.23B USD
Trailing P/E N/A
Forward P/E 61.3787
PEG Ratio (5 yr expected) 1.62
Price/Sales (ttm) 12.916307
Price/Book (mrq) 4.4118605
Enterprise Value/Revenue 12.704
Enterprise Value/EBITDA 71.323

Trading Information

Repligen Stock Price History

Beta (5Y Monthly) 1.117
52-Week Change 12.61%
S&P500 52-Week Change 13.32%
52 Week High 198.87 USD
52 Week Low 100.99 USD
50-Day Moving Average 177.15 USD
200-Day Moving Average 145.27 USD

RGEN Share Statistics

Avg. Volume (3 month) 1.19M USD
Avg. Daily Volume (10-Days) 1.01M USD
Shares Outstanding 63.92M
Float 60.96M
Short Ratio 4.88
% Held by Insiders 6.14%
% Held by Institutions 114.39%
Shares Short 7.05M
Short % of Float 11.06%
Short % of Shares Outstanding 11.03%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -1.46%
Operating Margin (ttm) 8.14%
Gross Margin 53.76%
EBITDA Margin 17.81%

Management Effectiveness

Return on Assets (ttm) 1.40%
Return on Equity (ttm) -0.56%

Income Statement

Revenue (ttm) 805.61M USD
Revenue Per Share (ttm) 14.28 USD
Quarterly Revenue Growth (yoy) 10.90%
Gross Profit (ttm) 433.14M USD
EBITDA 143.5M USD
Net Income Avi to Common (ttm) -11804000 USD
Diluted EPS (ttm) -0.21
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 862.98M USD
Total Cash Per Share (mrq) 13.5 USD
Total Debt (mrq) 692.24M USD
Total Debt/Equity (mrq) 33.09 USD
Current Ratio (mrq) 9.882
Book Value Per Share (mrq) 36.896

Cash Flow Statement

Operating Cash Flow (ttm) 129.86M USD
Levered Free Cash Flow (ttm) 111.58M USD

Profile of Repligen

Country United States
State MA
City Waltham
Address Building 1
ZIP 02453
Phone 781 250 0111
Website https://www.repligen.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 2000

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Q&A For Repligen Stock

What is a current RGEN stock price?

Repligen RGEN stock price today per share is 162.78 USD.

How to purchase Repligen stock?

You can buy RGEN shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Repligen?

The stock symbol or ticker of Repligen is RGEN.

Which industry does the Repligen company belong to?

The Repligen industry is Medical Instruments & Supplies.

How many shares does Repligen have in circulation?

The max supply of Repligen shares is 63.92M.

What is Repligen Price to Earnings Ratio (PE Ratio)?

Repligen PE Ratio is now.

What was Repligen earnings per share over the trailing 12 months (TTM)?

Repligen EPS is -0.21 USD over the trailing 12 months.

Which sector does the Repligen company belong to?

The Repligen sector is Healthcare.

Repligen RGEN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24509.76 USD —
-2.49
8.22B USD — 24460.28 USD — 24882.04 USD — — 8.22B USD —
us US Tech Global Select Market Com NQGS US 12071.97 USD —
-2.48
— — 12047.15 USD — 12254.16 USD — — — —
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
— — 2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD — — —
us US Tech Composite Total Return XCMP US 30288.13 USD —
-2.49
— — 30226.99 USD — 30748.16 USD — — — —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3666.28 USD —
-2.18
— — 3658.64 USD — 3712.3 USD — — — —
us US Tech Next Generation 100 Inde NGX US 1716.25 USD —
-2.17
— — 1714.29 USD — 1740.5 USD — — — —
us US Tech Health Care IXHC US 1342.75 USD —
-1.87
— — 1340.49 USD — 1374 USD — — — —
us US Tech Biotechnology Total Retu XNBI US 7723.64 USD —
-1.98
— — 7706.73 USD — 7919.79 USD — — — —
$2.18T
Total marketcap
$75.14B
Total volume
BTC 59.09%   •   ETH 10.15%
Dominance
Select currency